Apelin Effects on Blood Pressure and RAS in DOCA-Salt-Induced Hypertensive Rats

REFERENCES

• Badyal DK, Lata H, Dadhich AP. Animal models of hypertension and effect of drugs. Indian J Pharmacol 2003; 35:349–362.
   Google Scholar
• Lerman LO, Chade AR, Sica V, Napoli C. Animal models of hypertension: an overview. J Lab Clin Med 2005; 146:160–173.
   PubMed Web of Science ®Google Scholar
• Guyton AC, Coleman TG, Cowley AW, Scheel KW, Manning RD, Norman RA. Arterial pressure regulation: overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 1972; 52:584–594.
   PubMed Web of Science ®Google Scholar
• Haack D, Möhring J, Möhring B, Petri M, Hackenthal E. Comparative study on development of corticosterone and DOCA hypertension in rats. Am J Physiol Renal Physiol 1977; 233:F403–F411.
   PubMed Web of Science ®Google Scholar
• Tatemoto K, Hosoya M, Habata Y, Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998; 251:471–476.
   PubMed Web of Science ®Google Scholar
• Lee DK, Cheng R, Nguyen T, . Characterization of apelin, the ligand for the APJ receptor. J Neurochem 2000; 74:34–41.
   PubMed Web of Science ®Google Scholar
• O’Dowd BF, Heiber M, Chan A, . A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 1993; 136:355–360.
   PubMed Web of Science ®Google Scholar
• Tatemoto K, Takayama K, Zou MX, . The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 2001; 99:87–92.
   PubMed Web of Science ®Google Scholar
• Charles CJ. Putative role for apelin in pressure/volume homeostasis and cardiovascular disease. Cardiovasc Hematol Agents Med Chem 2007; 5:1–10.
   PubMedGoogle Scholar
• Ishida J, Hashimoto T, Hashimoto Y, Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo. J Biol Chem 2004; 279:26274–26279.
   PubMed Web of Science ®Google Scholar
• Lee DK, Saldivia VR, Nguyen T, Chen R, George SR, O’Dowd BF. Modification of the terminal residue of apelin-13 antagonizes its hypotensive action. Endocrinology 2005; 146:231–236.
   PubMed Web of Science ®Google Scholar
• Bhatia J, Tabassum F, Sharma AK, . Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stress. Cardiovasc Toxicol 2011; 11:272–279.
   PubMed Web of Science ®Google Scholar
• Falcao-Pires I, Goncalves N, Henriques-Coelho T, Moreira-Goncalves D, Roncon Albuquerque R, Leite-Moreira AF. Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 2009; 296:2007–2014.
   PubMed Web of Science ®Google Scholar
• Erken HA, Erken G, Genç O. Blood pressure measurement in freely moving rats by the tail cuff method. Clin Exp Hypertens 2013; 35:11–15.
   PubMed Web of Science ®Google Scholar
• Larouche I, Schiffrin EL. Cardiac mikrovasculature in DOCA-salt hypertensive rats effect of endothelin ETA receptor antagonism. Hypertension 1999; 34:795–801.
   PubMed Web of Science ®Google Scholar
• Veeramani C, Al-Numair KS, Chandramohan G, Alsaif MA, Pugalendi KV. Protective effect of Melothria maderaspatana leaf fraction on electrolytes, catecholamines, endothelial nitric oxide synthase and endothelin-1 peptide in uninephrectomized deoxycorticosterone acetate–salt hypertensive rats. J Nat Med 2011; 10(1007): 11418–011–0621.
   Google Scholar
• Raij L. Hypertension and Cardiovascular risk factors: role of the angiotensin II–nitric oxide interaction. Hypertension 2001; 37:767–773.
   PubMed Web of Science ®Google Scholar
• Day R, Lariviere R, Schiffrin EL. In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Am J Hypertens 1995; 8:294–300.
   PubMed Web of Science ®Google Scholar
• Hong HJ, Chan P, Liu JC, Angiotensin II induces endothelin-1 gene expression via extracellular signal-regulated kinase pathway in rat aortic smooth muscle cells. Cardiovasc Res 2004; 61:159–168.
   PubMed Web of Science ®Google Scholar
• Rakugi H, Tabuchi Y, Nakamaiu M, Endothelin activates the vascular renin angiotensin system in rat mesenteric arteries. Biochem Int 1990; 21:867–872.
   PubMedGoogle Scholar
• Rossi GP, Colonna S, Pavan E. Endothelin-1 and its mRNA in the wall layers of human arteries at vivo. Circulation 1999; 99:1147–1155.
   PubMed Web of Science ®Google Scholar
• Schiffrin EL. Role of Endothelin-1 in hypertension and vascular disease. Am J Hypertens 2001; 14:83–89.
   PubMed Web of Science ®Google Scholar
• Seo B, Oemar BS, Siebenmann R, Von Segersen L, Luscher TF. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 1994; 89:1203–1208.
   PubMed Web of Science ®Google Scholar
• Haynes WG, Strachan FE, Webb DJ. Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation 1995; 92:357–363.
   PubMed Web of Science ®Google Scholar
• Lee DK, Saldivia VR, Nguyen T, . Modification of the terminal residue of apelin-13 antagonizes its hypotensive action. Endocrinology 2005; 146:231–236.
   PubMed Web of Science ®Google Scholar
• Andersen CU, Markvardsen LH, Hilberg O, Simonsen U. Pulmonary apelin levels and effects in rats with hypoxic pulmonary hypertension. Respir Med 2009; 103:1663–1671.
   PubMed Web of Science ®Google Scholar
• Iwanaga Y, Kihara Y, Takenaka H, Kita T. Down-regulation of cardiac apelin system in hypertrophied and failing hearts: possible role of angiotensin II-angiotensin type 1 receptor system. J Mol Cell Cardiol 2006; 41:798–806.
   PubMed Web of Science ®Google Scholar
• Zhong JC, Huang DY, Liu GF, Effects of all-trans retinoic acid on orphan receptor APJ signaling in spontaneously hypertensive rats. Cardiovasc Res 2005; 65:743–750.
   PubMed Web of Science ®Google Scholar
• Crackower M, Sarao R, Oudit G, Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002; 417:822–828.
   PubMed Web of Science ®Google Scholar
• Vickers C, Hales P, Kaushik V, Hydrolysis of biological peptides by human angiotensin-converting enzymerelated carboxypeptidase. J Biol Chem 2002; 277:14838–14843.
   PubMed Web of Science ®Google Scholar
• Gómez-Guzmán M, Jiménez R, Zarzuelo SM. Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension. Free Radic Biol Med 2012; 52:70–79.
   PubMed Web of Science ®Google Scholar
• Sunter D, Hewson AK, Dickson SL. Intracerebroventricular injection of apelin-13 reduces food intake in the rat. Neurosci Lett 2003; 353:1–4.
   PubMed Web of Science ®Google Scholar
• O’Shea M, Hansen MJ, Tatemoto K, Morris MJ. Inhibitory effect of apelin-12 on nocturnal food intake in the rat. Nutr Neurosci 2003; 6:163–167.
   PubMed Web of Science ®Google Scholar
• Valle A, Hoggard N, Adams AC, Roca P, Speakman JR. Chronic central administration of apelin-13 over 10 days increases food intake, body weight, locomotor activity and body temperature in C57BL/6 mice. J Neuroendocrinol 2008; 20:79–84.
   PubMed Web of Science ®Google Scholar
• Higuchi K, Masaki T, Gotoh K, An APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice. Endocrinology 2007; 148:2690–2697.
   PubMed Web of Science ®Google Scholar